Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG for Prevention of BKV Infection in Kidney Transplant Recipients
NCT04222023Phase 4Completed
- Sponsor
- Strasbourg University Hospital
- Start
- Aug 2022
- Primary completion
- Aug 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of intravenous immunoglobulin G in BK virus infection, sponsored by Strasbourg University Hospital. Started Aug 2022; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
BK virus infection
Beyond the preview
Go deeper on NCT04222023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04222023.